Package 55513-519-30

Brand: otezla

Generic: apremilast
NDC Package

Package Facts

Identity

Package NDC 55513-519-30
Digits Only 5551351930
Product NDC 55513-519
Description

30 TABLET, FILM COATED in 1 BOTTLE (55513-519-30)

Marketing

Marketing Status
Marketed Since 2025-08-31
Brand otezla
Generic apremilast
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d869faaf-a5ad-4b12-b427-06587d17787e", "openfda": {"nui": ["N0000182961", "N0000182960"], "upc": ["0355513137607"], "unii": ["UP7QBP99PN"], "rxcui": ["1492732", "1492738", "1492740", "1492742", "1492744", "1492746", "1492747", "1492748", "1605454", "1605455", "2682429", "2682430", "2682431", "2682432", "2723448", "2723452", "2724366", "2724367"], "spl_set_id": ["f6b1f516-4972-4d82-bced-113e47b41cc5"], "pharm_class_epc": ["Phosphodiesterase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 4 Inhibitors [MoA]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (55513-519-30)", "package_ndc": "55513-519-30", "marketing_start_date": "20250831"}], "brand_name": "Otezla", "product_id": "55513-519_d869faaf-a5ad-4b12-b427-06587d17787e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 4 Inhibitor [EPC]", "Phosphodiesterase 4 Inhibitors [MoA]"], "product_ndc": "55513-519", "generic_name": "apremilast", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Otezla", "active_ingredients": [{"name": "APREMILAST", "strength": "75 mg/1"}], "application_number": "NDA205437", "marketing_category": "NDA", "marketing_start_date": "20250831", "listing_expiration_date": "20271231"}